Regeneron Pharmaceuticals shares owned by Gluskin Sheff + Associates
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Gluskin Sheff + Associates
from 13F filings
Historical chart of Gluskin Sheff + Associates investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Gluskin Sheff + Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Gluskin Sheff + Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $2.6M | 3.2k | 822.96 |
| 2023-06-30 | $2.6M | 3.6k | 718.54 |
| 2023-03-31 | $3.8M | 4.6k | 821.67 |
| 2022-12-31 | $4.9M | 6.8k | 721.49 |
| 2022-09-30 | $4.6M | 6.7k | 688.91 |
| 2022-06-30 | $4.0M | 6.7k | 591.09 |
| 2022-03-31 | $4.8M | 6.8k | 698.37 |
More positions owned by Gluskin Sheff + Associates
View all positions for Gluskin Sheff + Associates